TOPNet, a collaboration between scientists from NTU and the Experimental Drug Development Centre, aims to develop new solutions to treat the ancient disease.
Students’ Making & Tinkering Project Emerges Winner in International Competition
NTU students Elysia and Christopher emerged winners in the 2021 Grass Roots Student Project Competition organised by RS Components, an MNC which specialises in electronics, automation and control components. Their project, the Remotely-Controlled Biological Microscope, was developed for the Making & Tinkering undergraduate course, which is offered by CoS.
College of Science Students Emerge Champions in 2021 International Natural Sciences Tournament!
Congratulations to Team Benthos on winning the International Natural Sciences Tournament (INST)! The INST Grand Finals concluded on 25 July 2021.
Nipping the Problem of Diabetic Wounds in the (Rose Cactus) Bud
Scientists in Nanyang Technological University (NTU Singapore) led by Professor James P Tam, have discovered a first-in-class, plant-derived epidermal growth factor (EGF) and an ultrastable analog for healing of chronic wounds, an unmet problem in treatment of diabetic wounds. This is the first EGF receptor agonist that is structurally different from all previous EGFs and first such growth factor found in plants – the rose cactus, used widely in Southeast Asia. Since aberrant regulation of EGF or its receptor is associated with certain type of cancers, their findings also open new avenues to develop targeted therapies for cancer.
Is controlling plant development possible?
Plant diseases are not only a nuisance to neighbourhood gardeners, but more importantly, have a direct impact on a country’s agri-food industry. Associate Professor Miao Yansong, a plant scientist from the NTU School of Biological Sciences, recently published a study that shed some light on the field of plant immune response against microbial pathogens.
Congrats to Kong Weijia, taking 1st place in Singapore in the Code Jam to I/O for Women!
Kong Weijia, a PhD student in the NTU School of Biological Sciences, finished 1st in Singapore and 12th worldwide (out of more than 6600 participants) in the Code Jam to I/O for Women, a coding competition organised by Google. Science@NTU caught up with Weijia to find out more about her experience with Code Jam, and her aspirations as a woman in science.
TOPNet 2nd Annual Symposium – New Approaches to TB Drug Discovery 25 – 27 May 2021
Tuberculosis (TB) continues to be one of the most serious infectious diseases in the world, accounting for 1.7 million deaths in 2019. Approximately a quarter of the world’s population is infected with the pathogen Mycobacterium tuberculosis in latent form. TB is of...
Silently Targeting Cancer
Discovering the first silencers that loop to regulate its target genes in the human genome, Assistant Professor Fullwood and her team might just be one step closer to finding a method for curing cancer.
NTU Singapore scientists design compound that targets enzyme linked to autoimmune disorders and severe COVID-19
When the body detects a pathogen, such as bacteria or viruses, it mounts an immune system response to fight this invader. In some people, the immune system overreacts, resulting in an overactive immune response that causes the body to injure itself, which may prove fatal in some cases.
Now, scientists from Nanyang Technological University, Singapore (NTU Singapore) have created a compound that could help to reduce this overactivation without impairing the body’s entire immune response.
Experiential Learning Using Real-World Data: Quantum Black X CoS X Castlery
NTU College of Science (CoS) has recently established a partnership with Quantum Black, a McKinsey company. They specialize in analytics and will provide case study mentorship for some of our CoS students. For a start, Quantum Black and CoS co-designed a case study-centric course for the School of Biological Sciences (SBS) MSc in Biomedical Data Science programme. CoS will work towards expanding this partnership so that more of our students will benefit in the future.